Birdwatch Note
2022-09-01 12:49:47 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The linked page says "The Panel recommends against the use of ivermectin for the treatment of COVID-19, except in clinical trials." The most recent large clinical trials "showed that the use of ivermectin for the treatment of COVID-19 had no clinical benefit" https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Written by 4D971DD119DA920463DF54524736E0A6
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1565076289740046338
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1565321015588229120
- noteId - 1565321015588229120
- participantId - 4D971DD119DA920463DF54524736E0A6
- noteAuthorParticipantId -
- createdAtMillis - 1662036587032
- tweetId - 1565076289740046338
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - CHALLENGING
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The linked page says "The Panel recommends against the use of ivermectin for the treatment of COVID-19, except in clinical trials." The most recent large clinical trials "showed that the use of ivermectin for the treatment of COVID-19 had no clinical benefit" https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2022-09-01 12:49:47 UTC (1662036587032) |
2022-09-27 17:14:23 UTC (1664298863750) |
CURRENTLY_RATED_HELPFUL | 2022-09-27 17:14:23 UTC (1664298863750) |
NEEDS_MORE_RATINGS | 2022-09-27 17:14:23 UTC (1664298863750) |
CURRENTLY_RATED_HELPFUL | 6D52E77119FC0A73F40D1C068C5E67531E16FA62CA9EF821895346168DDF9704 |
| 2022-09-01 12:49:47 UTC (1662036587032) |
2022-09-27 17:14:23 UTC (1664298863750) |
CURRENTLY_RATED_HELPFUL | 2022-09-27 17:14:23 UTC (1664298863750) |
NEEDS_MORE_RATINGS | 2022-09-27 17:14:23 UTC (1664298863750) |
CURRENTLY_RATED_HELPFUL | 4D971DD119DA920463DF54524736E0A6 |
Note Ratings
| rated at | rated by | |
| 2022-09-01 14:42:13 -0500 | 0970AF2EDBB2160765D64BA2ADD89F73D654E9F9EC01C4671E82A8F98561183F | Rating Details |
| 2022-09-01 11:59:43 -0500 | 0AB689C453F1E569091558B03440721F | Rating Details |
| 2022-09-02 02:06:33 -0500 | 0BDF79D9155FB91689E6E47F6DCA7E7F | Rating Details |
| 2022-09-01 18:31:23 -0500 | 0C91900F7892D8DA899BB85193A8758A | Rating Details |
| 2022-09-05 07:33:46 -0500 | 152C664EC474246EB3D5BD53CBEFF1A9 | Rating Details |
| 2022-09-01 13:30:22 -0500 | 238938F8A35959DAFA9518817DEB65AA | Rating Details |
| 2022-09-02 02:06:33 -0500 | 3A2F1ADF0748E65F3E245026E636ABEDFA0FAA62A0D64F3FD8967743457AF105 | Rating Details |
| 2022-09-01 10:34:58 -0500 | 51CF24E741A18508E181F80408E6E7E109FDDE98B31A9F11F05480731FF485A6 | Rating Details |
| 2022-09-01 10:34:58 -0500 | 5AD0B5581E4AC4683F4A8D75DEB62680 | Rating Details |
| 2022-09-01 11:27:26 -0500 | 6C4D39819380C974F26A34B6C85405BD | Rating Details |
| 2022-09-01 15:22:42 -0500 | 7F76CA161BE12BCE9D960C6542DDBAB6 | Rating Details |
| 2022-09-01 13:30:22 -0500 | 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E | Rating Details |
| 2022-09-01 15:22:42 -0500 | 98D8319CF00FF86895E7E8055E5BC6976E94DBD9AA49EDD7F395F81FB2F9AC2D | Rating Details |
| 2022-09-01 11:27:26 -0500 | 9FDF9893DFAB4D45202E6558FAE3342DA24DFA5D58A9F7C14A2CF2DD79A3E176 | Rating Details |
| 2022-09-05 07:33:46 -0500 | A227869B752DF62F7538C29F2D2D225BAE499F3095FF33A985D81DD1C622A0E8 | Rating Details |
| 2022-09-01 18:31:23 -0500 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
| 2022-09-01 11:59:43 -0500 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
| 2022-09-01 14:42:13 -0500 | A87524982D71DEDE3399EB34174E1E0A | Rating Details |
| 2022-09-02 10:09:49 -0500 | EB16BFD619695609A34C9A2339FDCF9517CB85019B8E8D3E9650B2CC2F64FD49 | Rating Details |
| 2022-09-02 10:09:49 -0500 | ED6BAE8439E71FEC3B4983E87D72634A | Rating Details |
| 2022-09-01 18:18:06 -0500 | F092EA4CB202B72F79AC43DE5CAF2DC7D60778EB0698DDEA8AB3EED4323C2245 | Rating Details |
| 2022-09-01 18:18:06 -0500 | FBD4C539ADDD48521B69767302DD70B1 | Rating Details |
| 2022-09-01 13:30:22 -0500 | Rating Details | |
| 2022-09-05 07:33:46 -0500 | Rating Details | |
| 2022-09-01 11:59:43 -0500 | Rating Details | |
| 2022-09-02 02:06:33 -0500 | Rating Details | |
| 2022-09-01 15:22:42 -0500 | Rating Details | |
| 2022-09-01 11:27:26 -0500 | Rating Details | |
| 2022-09-01 18:31:23 -0500 | Rating Details | |
| 2022-09-01 10:34:58 -0500 | Rating Details | |
| 2022-09-02 10:09:49 -0500 | Rating Details | |
| 2022-09-01 14:42:13 -0500 | Rating Details |